Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 53
Filter
1.
Biomedicines ; 11(9)2023 Sep 19.
Article in English | MEDLINE | ID: mdl-37761008

ABSTRACT

BACKGROUND: Methotrexate (MTX) is one of the most extensively used drugs in the treatment of moderate-to-severe psoriasis (PS). However, it frequently must be suspended owing to the toxicity in certain patients. OBJECTIVE: To evaluate the influence of ABCC1, ABCG2, and FOXP3 in the development of MTX toxicity in PS. METHODS: Retrospective cohort study with 101 patients. Five single-nucleotide polymorphisms (SNPs) were genotyped using real-time polymerase chain reaction with TaqMan probes. RESULTS: Patients carrying ABCC1 rs2238476-AG genotype (AG vs. GG: OR = 8.04; 95% CI = 1.48-46.78; p = 0.015); FOXP3 rs376154-GT and GG genotypes (GT vs. TT/GG: OR = 3.86; 95% CI = 1.17-13.92; p = 0.031) and ABCG2 rs13120400-T allele (T vs. CC: OR = 8.33; 95% CI = 1.24-164.79; p = 0.059) showed a higher risk of developing more than one adverse effect. The toxicity analysis by subtypes showed that the ABCC1 rs2238476-AG genotype (AG vs. GG: OR = 8.10; 95% CI = 1.69-46.63; p = 0.011) and FOXP3 rs376154-GT genotype (OR = 4.11; 95% CI = 1.22-15.30; p = 0.027) were associated with the appearance of asthenia. No association of the other ABCC1 polymorphisms (rs35592 and rs246240) with MTX toxicity was found. CONCLUSION: ABCC1, ABCG2, and FOXP3 polymorphisms can be considered to be risk biomarkers of toxicities in PS patients treated with MTX.

5.
Pediatr Dermatol ; 40(3): 537-539, 2023.
Article in English | MEDLINE | ID: mdl-36394113

ABSTRACT

We report the case of a neonate presenting with the clinical features of blueberry muffin syndrome caused by ganglioneuroblastoma, a rare variant of neuroblastoma. This syndrome may be the only visible manifestation of a neonatal tumor and highlights the importance of early recognition and initiation of therapy to reduce mortality.


Subject(s)
Ganglioneuroblastoma , Infant, Newborn , Infant , Humans , Syndrome
7.
J Clin Med ; 11(12)2022 Jun 10.
Article in English | MEDLINE | ID: mdl-35743415

ABSTRACT

Epidermal barrier dysfunction plays an important role in atopic dermatitis (AD). The difficulty of objectively assessing AD severity and the introduction of new biologicals into clinical practice highlight the need to find parameters to monitor clinical outcomes. The aim of this study is to evaluate the impact of dupilumab on skin barrier function and compare it with other treatments in patients with AD. A prospective observational study was conducted in adults with AD treated with topical corticosteroids (TCS), cyclosporine, or dupilumab. The main outcome measures after 16 weeks of treatment were Eczema Area and Severity (EASI)-50 (50% improvement in EASI), and transepidermal water loss (TEWL)-50 (50% improvement in TEWL). Forty-six patients with AD were included in the study. The proportion of patients who achieved EASI-50 at week 16 was significantly higher in patients receiving dupilumab (81.8% vs. 28.6% vs. 40%, p = 0.004). In eczematous lesions, TEWL decreased in patients receiving dupilumab (31.02 vs. 12.10 g·h−1·m−2, p < 0.001) and TCS (25.30 vs. 14.88 g·h−1·m−2, p = 0.047). The proportion of patients who achieved TEWL-50 at week 16 was higher for dupilumab than for cyclosporine or TCS. Temperature only decreased in the dupilumab group. Stratum corneum hydration increased in eczematous lesions and non-involved skin only in patients with dupilumab. In conclusion, dupilumab improves skin barrier function in patients with AD better than TCS or cyclosporine, both in eczematous lesions and in non-lesioned skin.

8.
Pediatr. aten. prim ; 24(94)abr. - jun. 2022. ilus
Article in Spanish | IBECS | ID: ibc-212124

ABSTRACT

Contexto: la alopecia areata es un proceso adquirido de base autoinmunitaria con prevalencia del 25% en la población infantil. Es una alopecia no cicatricial que puede desencadenarse por estrés. Tiene alta incidencia y se asocia a otras condiciones autoinmunes. Los niños han estado sometido a altos niveles de tensión emocional durante la pandemia COVID-19. Caso clínico: se presentan cuatro casos de pacientes pediátricos de una consulta de pediatría de atención primaria acontecidos durante el periodo de confinamiento por la pandemia COVID-19. Dos de los pacientes recibieron atención en la Unidad de Dermatología infantil debido a la rápida progresión. Uno de los casos, con placa alopecia aislada, presentó evolución favorable sin necesidad de tratamiento con resolución espontánea. Fue necesaria la atención psicológica en dos de los menores. Conclusiones: la situación vivida en la pandemia ha desencadenado brotes de enfermedades dermatológicas con influencia psicológica, como psoriasis, urticaria crónica, dermatitis atópica, efluvio telógeno y alopecia areata. Es quizás el estrés agudo (menor de 2 meses de duración) el que puede influir más. La relación entre alopecia areata y desórdenes psiquiátricos es un círculo vicioso: tanto el estrés puede desencadenarla como, a su vez, la aparición de la misma puede derivar en trastornos ansioso depresivos con efectos sociales que influyen en la calidad de vida y que pueden requerir atención psicológica (AU)


Context: alopecia areata is an acquired autoimmune disease with a prevalence of 25% in children. It is a non-scarring form of alopecia that can be triggered by stress. Its incidence is high and it is associated with other autoimmune diseases. Children have endured high levels of emotional stress during the COVID-19 pandemic.Cases presented: we present 4 cases in paediatric patients managed in a primary care paediatrics clinic that occurred during the lockdown imposed due to the COVID-19 pandemic. Two of the patients received care in the paediatric dermatology unit due to rapid progression. One of the patients with an isolated plaque of alopecia had a favourable outcome without treatment, with spontaneous resolution. Two of the patients required psychological care.Conclusions: the circumstances experienced during the pandemic have triggered outbreaks of dermatological diseases with a psychogenic component such as psoriasis, chronic urticaria, atopic dermatitis, telogen effluvium and alopecia areata; acute stress (duration <2 months) may have the greatest impact. The relationship between alopecia areata and psychiatric disorders is a vicious circle, as stress can trigger alopecia areata and in turn its development can lead to anxiety and depressive disorders with a social impact that impair quality of life and may require psychological care. (AU)


Subject(s)
Humans , Male , Female , Child, Preschool , Child , Coronavirus Infections/psychology , Pneumonia, Viral/psychology , Pandemics , Alopecia Areata/psychology
9.
Pediatr Dermatol ; 39(4): 557-562, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35504688

ABSTRACT

BACKGROUND: Guidelines and expert recommendations on infantile hemangiomas (IH) are aimed at increasing homogeneity in clinical decisions based on the risk of sequelae. OBJECTIVE: The objective was to analyze the inter- and intra-observer agreement among pediatric dermatologists in the choice of treatment for IH. METHODS: We performed a cross-sectional inter-rater and intra-rater agreement study within the Spanish infantile hemangioma registry. Twenty-seven pediatric dermatologists were invited to participate in a survey with 50 clinical vignettes randomly selected within the registry. Each vignette contained a picture of an infantile hemangioma with a clinical description. Raters chose therapy among observation, topical timolol, or oral propranolol. The same survey reordered was completed 1 month later to assess intra-rater agreement. Vignettes were stratified into hemangioma risk categories following the Spanish consensus on IH. The agreement was measured using kappa statistics appropriate for the type of data (Gwet's AC1 coefficient and Gwet's paired t test). RESULTS: Twenty-four dermatologists completed the survey. Vignettes represented 7.8% of the Spanish hemangioma registry. The inter-rater agreement on the treatment decision was fair (AC1  = 0.39, 95% confidence interval [CI]: 0.30-0.47). When stratified by risk category, good agreement was reached for high-risk hemangiomas (AC1  = 0.77, 95% CI: 0.51-1.00), whereas for intermediate- and low-risk categories, the agreement was only fair (AC1 0.31, 95% CI: 0.16-0.46 and AC1  = 0.38, 95% CI: 0.27-0.48, respectively). Propranolol was the main option for high-risk hemangiomas (86.4%), timolol for intermediate-risk (36.8%), and observation for low-risk ones (55.9%). The intra-rater agreement was good. The inter-rater agreement between pediatric dermatologists on the treatment of IH is only fair. Variability was most significant with intermediate- and low-risk hemangiomas.


Subject(s)
Hemangioma, Capillary , Hemangioma , Child , Cross-Sectional Studies , Dermatologists , Hemangioma/drug therapy , Humans , Observer Variation , Pediatrics , Propranolol/therapeutic use , Spain , Timolol/therapeutic use
11.
Life (Basel) ; 12(1)2022 Jan 17.
Article in English | MEDLINE | ID: mdl-35054525

ABSTRACT

Skin is damaged in atopic dermatitis (AD) patients. Age is also believed to have a negative effect on epidermal barrier function. The aim of this study was to investigate skin barrier function changes with age in AD patients. A cross-sectional study was conducted including 162 participants, 81 AD patients and 81 healthy volunteers. Skin barrier function parameters, such as transepidermal water loss (TEWL), erythema, temperature, stratum corneum hydration (SCH), pH, and elasticity, were evaluated. Healthy volunteers were evaluated on the volar forearm. AD patients were measured on two regions: on an eczematous lesion on the volar forearm and on a non-involved area 5 cm from the affected area. TEWL was lower on healthy skin than uninvolved AD skin (9.98 vs. 25.51 g·m-2·h-1, p < 0.001) and AD eczematous lesions (9.98 vs. 28.38 g·m-2·h-1, p < 0.001). SCH was lower on AD eczematous lesions than uninvolved AD skin (24.23 vs. 39.36 AU, p < 0.001) and healthy skin (24.23 vs. 44.36 AU, p < 0.001). Elasticity was lower on AD eczematous lesions than uninvolved AD skin (0.69 vs. 0.74, p = 0.038) and healthy skin (0.69 vs. 0.77, p = 0.014). A negative correlation was found between age and elasticity in all the population (r = -0.383, p < 0.001). This correlation was stronger in AD patients (r = -0.494, p < 0.001) than in controls (r = -0.266, p = 0.092). After conducting a linear regression model in AD patients adjusted by age, sex, and SCORing Atopic Dermatitis (SCORAD), it was found that elasticity was impaired by an increasing age (ß = -0.004, p < 0.001) and a higher SCORAD (ß = -0.003, p < 0.001). The skin barrier function is impaired by age and AD, reflected mainly in poor elasticity values in older AD patients.

12.
J Clin Med ; 10(19)2021 Oct 08.
Article in English | MEDLINE | ID: mdl-34640625

ABSTRACT

Genetic variants that result in truncation in desmoplakin (DSP) are a known cause of arrhythmogenic cardiomyopathy (AC). In homozygous carriers, the combined involvement of skin and heart muscle is well defined, however, this is not the case in heterozygous carriers. The aim of this work is to describe cutaneous findings and analyze the molecular and ultrastructural cutaneous changes in this group of patients. Four women and eight men with a mean age of 48 ± 14 years were included. Eight met definitive criteria for AC, one was borderline and three were silent carriers. No relevant macroscopic changes in skin and hair were detected. However, significantly lower skin temperature (29.56 vs. 30.97 °C, p = 0.036) and higher transepidermal water loss (TEWL) (37.62 vs. 23.95 g m 2 h 1, p = 0.028) were observed compared to sex- and age-matched controls. Histopathology of the skin biopsy showed widening of intercellular spaces and acantholysis of keratinocytes in the spinous layer. Immunohistochemistry showed a strongly reduced expression of DSP in all samples. Trichogram showed regular nodules (thickening) compatible with pseudomonilethrix. Therefore, regardless of cardiac involvement, heterozygous patients with truncation-type variants in DSP have lower skin temperature and higher TEWL, constant microscopic skin involvement with specific patterns and pseudomonilethrix in the trichogram.

13.
J Clin Med ; 10(18)2021 Sep 20.
Article in English | MEDLINE | ID: mdl-34575367

ABSTRACT

Oral minoxidil is an approved treatment for high blood pressure which is also used as an off-label drug for alopecia. Knowledge about the effects of systemic minoxidil in the paediatric population is limited. A retrospective case series study of paediatric patients with history of systemic minoxidil intake due to contaminated sets of omeprazole was performed to describe side effects of high dose oral minoxidil intake in children. Twenty patients aged between 2 months and 13 years joined the study. They had received high doses of oral minoxidil (mean dose 0.90 mg/kg/day) during a mean time of 38.3 days. Hypertrichosis appeared in 65%, with a mean latency time of 24.31 days. Treatment time was associated with the appearance of hypertrichosis (p < 0.05). Most common initial zone of hypertrichosis was the face. Systemic effects developed in 15%, with no cases of severe disorders. The present study shows a novel insight into the side effects of high doses of oral minoxidil in children.

14.
Dermatopathology (Basel) ; 8(1): 49-53, 2021 Mar 09.
Article in English | MEDLINE | ID: mdl-33803120

ABSTRACT

Griscelli syndrome (GS) is a rare disease that is characterized by silvery hair and fair skin. It is included in congenital grey hair syndromes, a rare group of autosomal recessive disorders characterized by silvery grey hair and severe multisystem disorders, such as immune system impairment, defects in immunological function, ocular and skeletal alterations, and nervous system defects. Herein, we report a rare case of GS type 1 and highlight the importance of a dermatological and hair examination to make an early diagnosis of these life-threatening diseases.

15.
Pediatr Rep ; 13(1): 131-134, 2021 Mar 16.
Article in English | MEDLINE | ID: mdl-33809406

ABSTRACT

Meyerson phenomenon, also known as "halo-eczema," has been widely described over melanocytic and non-melanocytic lesions. However, its appearance over vascular anomalies is rarely observed and could lead to diagnostic errors. A case study of five patients aged between four months and two years is reported. These patients developed unique erythematous and pruritic scaly patches, being diagnosed and treated as fungal infections. Due to the lack of response to the treatment, they were referred to the pediatric dermatology practice, where the diagnosis of Meyerson phenomenon over capillary malformations was made. Topical treatment with corticosteroids led to improvement in all cases. Although Meyerson phenomenon developing over vascular anomalies is a rare condition, it is important for pediatricians and dermatologists to assess it as a part of the differential diagnosis when treating a patient with skin lesions. Recognizing this phenomenon will prevent diagnostic and therapeutic errors.

16.
Allergol. immunopatol ; 49(2): 1-5, mar. 2021. tab, graf
Article in English | IBECS | ID: ibc-214231

ABSTRACT

Introduction Atopic dermatitis is a highly prevalent chronic disorder. Therapeutic education in diseases of this kind is essential in order to improve patient management and prognosis. A study was conducted regarding parent satisfaction following educational sessions in an Atopy School organized by a multidisciplinary team. Material and methods E-mail surveys with variables scored by means of a Likert scale were administered among the parents participating in the workshops organized by the Atopy School. The educational program comprised four sessions with a duration of 4 hours. Results Ninety-five percent of the parents were satisfied after participating in the workshops, and were of the opinion that the therapeutic education received was useful for improving control of the illness of their children. Likewise, 85% were satisfied or very satisfied with the help received in the sessions for control of the disease during flare-ups, and 90% considered the data and advice received in the sessions to be of use in improving quality of life of both the children and the family as a whole. Conclusions The Atopy School afforded caregiver empowerment, and the parents were satisfied and felt more secure in dealing with the disease of their children—thereby improving the prognosis and quality of life (AU)


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Child , Health Knowledge, Attitudes, Practice , Parents/education , Caregivers/education , Dermatitis, Atopic/therapy , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/immunology , Patient Education as Topic/methods , Patient Education as Topic/organization & administration , Prognosis , Program Evaluation , Severity of Illness Index , Quality of Life
17.
Allergol Immunopathol (Madr) ; 49(2): 1-5, 2021.
Article in English | MEDLINE | ID: mdl-33641287

ABSTRACT

INTRODUCTION: Atopic dermatitis is a highly prevalent chronic disorder. Therapeutic education in diseases of this kind is essential in order to improve patient management and prognosis. A study was conducted regarding parent satisfaction following educational sessions in an Atopy School organized by a multidisciplinary team. MATERIAL AND METHODS: E-mail surveys with variables scored by means of a Likert scale were administered among the parents participating in the workshops organized by the Atopy School. The educational program comprised four sessions with a duration of 4 hours. RESULTS: Ninety-five percent of the parents were satisfied after participating in the workshops, and were of the opinion that the therapeutic education received was useful for improving control of the illness of their children. Likewise, 85% were satisfied or very satisfied with the help received in the sessions for control of the disease during flare-ups, and 90% considered the data and advice received in the sessions to be of use in improving quality of life of both the children and the family as a whole. CONCLUSIONS: The Atopy School afforded caregiver empowerment, and the parents were satisfied and felt more secure in dealing with the disease of their children-thereby improving the prognosis and quality of life.


Subject(s)
Caregivers/education , Dermatitis, Atopic/therapy , Health Knowledge, Attitudes, Practice , Parents/education , Patient Education as Topic/organization & administration , Child , Child, Preschool , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/immunology , Female , Humans , Infant , Infant, Newborn , Male , Patient Education as Topic/methods , Prognosis , Program Evaluation , Quality of Life , Severity of Illness Index
18.
Acta Derm Venereol ; 100(10): adv00150, 2020 May 28.
Article in English | MEDLINE | ID: mdl-32374410

ABSTRACT

The aim of this study was to determine the prevalence and type of cutaneous manifestations which occur in patients with granulomatosis with polyangiitis and to explore the potential association between cutaneous and systemic involvement in these patients. A retrospective case series study was designed, including all granulomatosis with polyangiitis cases diagnosed between 2010 and 2018 at the Hospital Universitario Virgen de las Nieves. Thirty-nine patients with granulomatosis with polyangiitis were identified, of which 53.85% presented cutaneous manifestations. In decreasing order of frequency, the types of cutaneous problems observed included: palpable purpura, mucocutaneous ulcers, subcutaneous nodules, pyoderma gangrenosum-like ulcers, digital necrosis, papulonecrotic lesions and livedo reticularis. Patients with palpable purpura presented a higher frequency of renal involvement (p = 0.008). Cutaneous manifestations of granulomatosis with polyangiitis may facilitate early disease diagnosis. Likewise, a manifestation such as palpable purpura may be a predictor of kidney damage.


Subject(s)
Granulomatosis with Polyangiitis/epidemiology , Granulomatosis with Polyangiitis/pathology , Skin Diseases/epidemiology , Skin Diseases/pathology , Skin/pathology , Adolescent , Adult , Aged , Anti-Infective Agents/therapeutic use , Biopsy , Early Diagnosis , Female , Granulomatosis with Polyangiitis/drug therapy , Humans , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Predictive Value of Tests , Prevalence , Prognosis , Retrospective Studies , Skin/drug effects , Skin Diseases/drug therapy , Spain/epidemiology , Young Adult
19.
Transbound Emerg Dis ; 67(6): 2423-2434, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32304278

ABSTRACT

The aim of this study was to explore Leishmania infantum epidemiology through a One Health approach that promotes a better estimation of leishmaniasis burden and a deeper understanding of the spatial distribution of the key actors of the parasite life cycle (vectors, reservoirs and humans). We conducted a 14-year mixed retrospective and prospective study of leishmaniasis cases in an endemic area in southern Spain (Granada province), to estimate the human incidence and its association with the vector presence, cryptic leishmaniasis rates and canine leishmaniasis prevalence. We found an annual linear increase in the incidence that cannot be fully explained by active case surveillance and the improvement of PCR diagnostic techniques. 49.4% of cases were not reported to the surveillance system. Approximately half of the human cases correspond to the visceral form that occurred more frequently in men; cutaneous, mucosal and cryptic forms were also detected. Leishmaniasis is no longer a disease of young children, accounting for a quarter of immunocompetent patients and most infected people remained asymptomatic. Human and canine leishmaniasis, cryptic or symptomatic, are present in the whole province, where there is a medium/high risk of the presence of Phlebotomus perniciosus, the main vector. We found association between the incidence of human leishmaniasis and the presence of the vector, but not with the prevalence of canine leishmaniasis and cryptic human leishmaniasis. A potential hot spot was also found, where high leishmaniasis incidence may be associated to the involvement of host species other than dogs.


Subject(s)
Leishmania infantum , Leishmaniasis, Visceral/epidemiology , Leishmaniasis/epidemiology , One Health , Animals , Asymptomatic Infections/epidemiology , Dog Diseases/epidemiology , Dogs , Female , Humans , Incidence , Insect Vectors , Leishmaniasis/veterinary , Leishmaniasis, Visceral/diagnosis , Leishmaniasis, Visceral/parasitology , Leishmaniasis, Visceral/veterinary , Male , Phlebotomus , Polymerase Chain Reaction , Prospective Studies , Retrospective Studies , Spain/epidemiology
20.
Pediatr Dermatol ; 37(3): 576-578, 2020 May.
Article in English | MEDLINE | ID: mdl-32126589

ABSTRACT

The presence of eczema and elevated IgE in pediatric patients does not always indicate atopic dermatitis. Rare genodermatoses may share this clinical presentation and should be considered in the differential diagnosis for patients with congenital immunodeficiency and severe refractory dermatitis. We describe a case of severe dermatitis, allergies, and metabolic wasting syndrome, due to a novel mutation in DSG1 gene, an additional example of this uncommon genetic disorder of desmosome function.


Subject(s)
Dermatitis, Exfoliative , Eczema , Hypersensitivity , Wasting Syndrome , Child , Dermatitis, Exfoliative/diagnosis , Dermatitis, Exfoliative/genetics , Desmoglein 1 , Eczema/diagnosis , Humans , Wasting Syndrome/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...